🚀 Plexāā Raises $4.5M Extension Round with THENA Capital fund

MedTech startup Plexāā raised $4.5 million in an extension round to fund the U.S. launch of its BLOOM⁴³ breast surgery device and prepare for Series A fundraising. The funding will also support development of future innovations beyond the award-winning BLOOM⁴³ platform.

“Our fund’s commercialisation support model is well-suited to help Plexāā expand into women’s health and adjacent categories where better outcomes and patient experiences are urgently needed."

— Tatum Getty, Founding General Partner of THENA Capital

PLUS - We're thrilled to have Tatum Getty and Esther Reynal de St Michel Richardot from THENA Capital speaking at WHW Europe 2025

🔗 Read More

‍

⚡French Femtech Secures €1.6M to Tackle PCOS with AI-Powered Digital Therapeutics

Clara Stephenson, Former EY Corporate Lawyer, raises €1.6M seed round to address PCOS with AI-driven Digital Health Platform - with the goal of increasing the healthy life expectancy for women

‍🔗 Read More

‍

💍 Progyny Partners with ŌURA to Integrate Wearable Data for Women's Health Journey

Progyny, a global leader in women's health solutions, announced a partnership with ŌURA, maker of the leading smart ring, to empower women with comprehensive health data and personalised insights.

“Taking control with physiologic data from the Oura Ring further supports Progyny’s focus on raising the bar and elevating health outcomes.”

— Janet Choi, Chief Medical Officer of Progyny

🔗 Read More

‍

🌱 Luma Fertility Raises $4M Seed Round Led by Peak XV's Surge to Transform Reproductive Healthcare in India

Luma Fertility raises $4 million in seed funding from Peak XV's Surge to scale its technology-driven fertility platform and address India's rising demand for compassionate reproductive healthcare.

“There is a clear need for consumer-first healthcare in India, especially in verticals like fertility. Luma’s patient-first, outcome-driven approach paves the way for better care.”‍

— Vijay Taparia, Chairman of B2V Ventures‍

🔗 Read More

‍

🧬 Juniper Genomics Raises $4.6M Seed Round with Amboy Street Investment

Juniper Genomics raised $4.6 million in seed funding with participation from Amboy Street Ventures to advance its groundbreaking embryo screening platform that combines whole-genome and transcriptome sequencing for improved IVF outcomes.

“Their ability to translate cutting-edge genomics into tangible clinical impact aligns with our mission to invest in transformative technologies in women’s and sexual health.”

— Carli Sapir, Founding Partner of Amboy Street Ventures‍

🔗 Read More

‍

‍🔬 The Blue Box Secures €3M Funding to Develop AI-Driven Urine Test for Breast Cancer Detection

Blue Box Biomedical Solutions has raised €3 million to advance its AI-powered urine-based breast cancer screening test through clinical trials, targeting CE marking by late 2026.

“This milestone allows us to move full speed ahead with our European clinical trials and regulatory roadmap.”

— Judit Giró, CEO & Co-Founder of The Blue Box

🔗 Read More‍‍

‍

🤖 AI-Powered Excellence for Mammography: Affidea and b-rayZ Join Forces Across Europe

This collaboration brings cutting-edge AI quality controls and instant diagnostic feedback to breast imaging centres across Europe, improving patient care and clinical confidence.

“This partnership – both strategic and financial – positions us in the right direction to accelerate innovation across our network...”

— Dr. Charles Niehaus, Executive Director for Affidea Group‍

🔗 Read More

‍

❌ Organon Halts Endometriosis Pain Treatment Development Following Failed Clinical Trial

Organon announced it will discontinue development of an experimental endometriosis treatment acquired through its Forendo Pharma purchase, after the drug failed to alleviate pelvic pain in clinical trials.

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!